» Articles » PMID: 8535870

Respiratory Illness in Families of Preterm Infants with Chronic Lung Disease

Overview
Date 1995 Nov 1
PMID 8535870
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

AIMS--To examine the relation, based on two types of questionnaires, between (1) chronic lung disease of the newborn (CLDN) and lower respiratory illness (LRI) in siblings, and between (2) CLDN and asthma, chronic obstruction pulmonary disease (COPD), or allergy in parents and grandparents. METHODS--Data from 209 children born before 32 weeks of gestation were randomly taken from the records of three neonatal units. Taking into account age and gender, the excess of LRI was calculated for each family compared with the average of all families. Subsequently whether CLDN was associated with an excess of LRI in the family was tested. RESULTS--Thirty one (14.8%) children were diagnosed as having CLDN. The family probability index for LRI did not differ between children with or without CLDN. The prevalence of COPD, asthma, and allergy in parents of children with CLDN was similar to that of children without CLDN. The prevalence of LRI was 18.1% in study children, 29.6% in children with CLDN, and 16.9% in children without CLDN (P < 0.01). These prevalences were higher compared with that of a group of term siblings (9.3%) (P = 0.05). CONCLUSIONS--These findings suggest that CLDN in preterm children is not related to a genetic or familial predisposition towards asthma, COPD, or allergy.

Citing Articles

Family history of asthma influences outpatient respiratory outcomes in children with BPD.

McGlynn J, Aoyama B, Collaco J, McGrath-Morrow S Pediatr Pulmonol. 2021; 56(10):3265-3272.

PMID: 34365734 PMC: 8928086. DOI: 10.1002/ppul.25603.


Chronic lung disease and subsequent respiratory symptoms.

Shaw N, Amegavie L Arch Dis Child Fetal Neonatal Ed. 1996; 74(2):F151.

PMID: 8777671 PMC: 2528541. DOI: 10.1136/fn.74.2.f151.

References
1.
NORTHWAY Jr W, ROSAN R, Porter D . Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med. 1967; 276(7):357-68. DOI: 10.1056/NEJM196702162760701. View

2.
Stenmark K, Eyzaguirre M, Westcott J, Henson P, Murphy R . Potential role of eicosanoids and PAF in the pathophysiology of bronchopulmonary dysplasia. Am Rev Respir Dis. 1987; 136(3):770-2. DOI: 10.1164/ajrccm/136.3.770. View

3.
Shennan A, Dunn M, Ohlsson A, Lennox K, Hoskins E . Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics. 1988; 82(4):527-32. View

4.
Bancalari E . Prediction of abnormal pulmonary follow-up in premature infants. Pediatrics. 1988; 82(4):670-1. View

5.
Andreasson B, Lindroth M, Mortensson W, SVENNINGSEN N, Jonson B . Lung function eight years after neonatal ventilation. Arch Dis Child. 1989; 64(1):108-13. PMC: 1791820. DOI: 10.1136/adc.64.1.108. View